Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Isracann Biosciences Inc
ISCNF
Cannabis
Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural...
Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ISCNF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(1002)
•••
Farlo2020
X
View Profile
View Bullboard History
Post by
Farlo2020
on Aug 18, 2022 5:41pm
IPOT Management
What are you bozos doing ? $0.035 share price. You have a recovering alcoholic junkie from the island as CEO. Costa Cana are home in the wall pot store, mostly on native land , that are barely
...more
(1002)
•••
Farlo2020
X
View Profile
View Bullboard History
Post by
Farlo2020
on Aug 03, 2022 8:24pm
Great job Phil…
This POS now sits at $0.04 what are you clowns doing ?
(149)
•••
Goodtoreadthis1
X
View Profile
View Bullboard History
Post by
Goodtoreadthis1
on Jun 27, 2022 12:27pm
Pilbara proves Goldman Sachs view of LI mkt wrong
Base metals Battery metals Coal Copper Gold Iron ore Lithium Nickel
...more
(1002)
•••
Farlo2020
X
View Profile
View Bullboard History
Post by
Farlo2020
on Jun 21, 2022 9:05am
CEO
What are you doing, if anything ? Explain how you are even qualified to run this company....you have zero experience your current venture in the pot works is a total disaster on
...more
(1002)
•••
Farlo2020
X
View Profile
View Bullboard History
Comment by
Farlo2020
on Jun 09, 2022 8:57pm
RE:RE:Phil, Sean, Darrell….. rest of you clowns
Deleting my posts ???? what experience does Phil have ? real experience not some BS appointment
(41)
•••
Stockqueen77
X
View Profile
View Bullboard History
Comment by
Stockqueen77
on Jun 07, 2022 12:10am
RE:Phil, Sean, Darrell….. rest of you clowns
Wow...Phil is leading this company...no experience....run run run!
(1002)
•••
Farlo2020
X
View Profile
View Bullboard History
Comment by
Farlo2020
on May 21, 2022 10:21am
RE:press-releases/2022/05/19/isracann
Lol who cares this is at $0.06
(18)
•••
Darshan2
X
View Profile
View Bullboard History
Post by
Darshan2
on May 19, 2022 5:32pm
press-releases/2022/05/19/isracann
News
(18)
•••
awshucks
X
View Profile
View Bullboard History
Post by
awshucks
on Apr 19, 2022 11:29am
isracann-biosciences-renews-
https://themarketherald.ca/isracann-biosciences-renews-leadership-to-meet-changing-demands-2022-04-18/News
(18)
•••
awshucks
X
View Profile
View Bullboard History
Post by
awshucks
on Apr 18, 2022 10:59am
Isracann appoints director, officers, VP
Isracann appoints director, officers, VP 2022-04-18 00:34 ET - News Release Mr. Phil Floucault reports ISRACANN BIOSCIENCES RENEWS LEADERSHIP TO MEET CHANGING DEMANDS
...more
(18)
•••
awshucks
X
View Profile
View Bullboard History
Post by
awshucks
on Apr 13, 2022 3:05pm
isracann-biosciences-acquires-natural health medicine
https://themarketherald.ca/isracann-biosciences-acquires-natural-health-medicine-developer-and-appoints-natural-health-products-officers-2022-04-13/news
(1002)
•••
Farlo2020
X
View Profile
View Bullboard History
Comment by
Farlo2020
on Apr 08, 2022 12:23am
RE:Isracann Biosciences Signs Definitive Agreement
Yet here the stock sits $0.075 lol
(2794)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Mar 28, 2022 8:45am
Isracann Biosciences Signs Definitive Agreement
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the
...more
(18)
•••
awshucks
X
View Profile
View Bullboard History
Post by
awshucks
on Mar 11, 2022 10:05am
leafly.com/news/politics/israel-decriminalizes-m
https://www.leafly.com/news/politics/israel-decriminalizes-marijuana-2022 Israel Rec
(18)
•••
awshucks
X
View Profile
View Bullboard History
Post by
awshucks
on Mar 07, 2022 4:35pm
Israel-set-to-decriminalize-rec-cannabis
Israel https://www.benzinga.com/markets/cannabis/22/03/26022267/israel-set-to-decriminalize-rec-cannabis-as-more-marijuana-businesses-join-the-emerging-market
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed
EnviroGold Global Announces Appointment of Chief Operating Officer